BFM
NTRP

Boston Financial Management’s Neurotrope, Inc. Common NTRP Stock Holding History

Boston Financial Management’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-43,787
Closed -$837K – 288
2017
Q1 		$837K Buy
+43,787
New +$829K 0.06% 183

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Boston Financial Management's NTRP Position: Q2 2017 in Review

Boston Financial Management sold out of Neurotrope, Inc. Common (NTRP) in Q2 2017, closing a stake of 43,787 shares — an estimated $837K sold.

Boston Financial Management first reported a position in NTRP in Q1 2017 and held it in 1 quarter. The position peaked at $837K in Q1 2017. 27 funds tracked by Wall St. Rank hold NTRP as of Q2 2017.

  • Boston Financial Management reported no remaining Neurotrope, Inc. Common position as of Q2 2017 after selling out during the quarter.
  • Boston Financial Management sold 43,787 Neurotrope, Inc. Common shares in Q2 2017, an estimated $837K.
  • Boston Financial Management first reported a position in Neurotrope, Inc. Common in Q1 2017 and held it in 1 quarter.
  • Boston Financial Management's Neurotrope, Inc. Common position peaked at $837K in Q1 2017.
  • 27 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q2 2017.

Based on Boston Financial Management's 13F filing for Q2 2017, filed 27 Jul 2017.